• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

113
97
78
60
59

COUNTRY

11
10
10
10
10

CATEGORIES

  • 329
  • 227
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

8
9
336
347

PUBLISHED

0
0
4
347

PRODUCT TYPE

339
6
2

Search "Snapshots US Prescription Pharmaceuticals 2008" returned 347 results.

Pharmaceuticals - Global Outlook

The global outlook series on Pharmaceuticals provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings Punctuated with 46 statistically rich tables, the...

January 2012
FROM

Asia Pacific: Pharmahandbook

Asia Pacific: Pharmahandbook: Australia, China, India, Indonesia, Japan, New Zealand, South Korea, Taiwan Intellectual property in India PBS access in Australia Generics in Japan And China What about...

June 2013
FROM

PharmaHandbook: United States 2013 Edition

$325 billion That's the size of the U S pharmaceutical market It translates to one-third of global industry sales but achieving success in the world's largest market is a lot tougher than it used to...

July 2013
FROM

The Future of the Pharmaceutical Packaging Industry - Emerging Economies Poised to Capitalize on Increasing Demand

“The Future of the Pharmaceutical Packaging Industry - Emerging Economies Poised to Capitalize on Increasing Demand” provides insights on the global pharmaceutical packaging market and gives information...

December 2009
FROM
Active Pharmaceutical Ingredients (API) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 Active Pharmaceutical Ingredients (API) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 - Product Thumbnail Image

Active Pharmaceutical Ingredients (API) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

'Active Pharmaceutical Ingredients (API) Market: (Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured, by Geography, and by Therapeutic Area) - Global Industry Analysis,...

March 2015
FROM
Tuberculosis Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 Tuberculosis Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 - Product Thumbnail Image

Tuberculosis Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

'Tuberculosis Testing Market (Smear Microscopy, Culture Based Tests, Nucleic Acid Testing, Mantoux Test, Radiography (Chest X-Ray), Drug Susceptibility Testing (DST) and Other TB Tests): Global Industry...

March 2015
FROM

CNS Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants,...

February 2015
FROM

Taiwan Pharmaceuticals and Healthcare Report Q2 2013

BMI View We continue viewing Taiwan as a relatively mature pharmaceutical market. As such, we forecast a compound annual growth rate (CAGR) of 3.5% in local currency terms and 5.2% in US dollar terms...

March 2013

Estonia Pharmaceuticals and Healthcare Report Q2 2012

Business Monitor International's Estonia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

February 2012

Hungary Pharmaceuticals and Healthcare Report Q2 2013

BMI View The Hungarian government's harsh measures aimed at reducing its debt have severely affected the domestic market for pharmaceutical companies, which have posted steep declines in domestic...

March 2013
China Pharmaceutical Industry Research and Forecast to 2016 China Pharmaceutical Industry Research and Forecast to 2016 - Product Thumbnail Image

China Pharmaceutical Industry Research and Forecast to 2016

The present report on “China Pharmaceutical Industry Research and Forecast to 2016” analyzes in detail the pharmaceutical industry environment with market sizing in terms of patented drugs, generic...

March 2012
FROM

Latvia Pharmaceuticals and Healthcare Report Q2 2012

Business Monitor International's Latvia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

February 2012

Noven Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report

Noven Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis,...

January 2013
FROM

Analyzing the Global Generics Industry 2014

In recent times there has been a growing focus on the generic drugs industry worldwide The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the...

August 2014
FROM

Pakistan Pharmaceuticals and Healthcare Report Q1 2013

BMI View: For new medicines to be launched into the Pakistani market, the pharmaceutical regulator must drop its requirement for local rigorous drug approvals and registration process. The country does...

December 2012

Sweden Pharmaceuticals and Healthcare Report Q2 2012

Business Monitor International's Sweden Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

February 2012

Pharyngitis - Pipeline Review, H1 2013

Pharyngitis - Pipeline Review, H1 2013 Summary 'Pharyngitis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the...

June 2013
FROM

Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS

“Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS”, provides key data, information...

May 2011
FROM

United Kingdom Pharmaceuticals and Healthcare Report Q4 2011

Business Monitor International's United Kingdom Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

October 2011

Italy Pharmaceuticals and Healthcare Report Q2 2012

Business Monitor International's Italy Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments...

February 2012
Loading Indicator

Our Clients

Amneal Pharmaceuticals LLC. Amgen Inc. LEO Laboratories Ltd. Pfizer, Inc. Roche Diagnostics Ltd. Merck & Co., Inc. Sanofi S.A.